Nalmefene Side Effects
Applies to nalmefene: injectable solution
Gastrointestinal side effects have occurred commonly, with nausea and vomiting observed in 18% and 9%, respectively, of treated patients. Diarrhea and dry mouth have been reported in less than 1% of patients.[Ref]
Cardiovascular adverse effects including tachycardia, hypertension, hypotension, vasodilation, bradycardia, and arrhythmia have been reported in 5% or fewer of treated patients.[Ref]
Nervous system side effects including postoperative pain, dizziness, headache, fever, and chills have been reported in less than 5% of treated patients. Somnolence, depression, agitation, nervousness, tremor, confusion, and myoclonus have been reported in less than 1% of patients.[Ref]
Nalmefene administration may precipitate acute and extended withdrawal symptoms in opioid-dependent patients.[Ref]
A 21-year-old male with no significant past medical history had decreased respirations following an exploratory laparotomy for presumed appendicitis. The patient developed acute pulmonary edema after receiving 75 mcg nalmefene in 25 mcg increments over 10 minutes. Clinical resolution of symptoms was prompt after supplemental oxygen and furosemide. It took 36 hours for the chest X-ray to improve.[Ref]
Respiratory side effects have included pharyngitis (less than 1%). Pulmonary edema is an uncommon effect that has occurred with nalmefene administration.[Ref]
Dermatologic side effects have infrequently included pruritus (less than 1%).[Ref]
Genitourinary side effects have included rare reports of urinary retention (less than 1%).[Ref]
Other side effects including fever (3%) and chills (1%) have been reported.
1. "Product Information. Revex (nalmefene)." Ohmeda Pharmaceutical Products Division, Liberty Corner, NJ.
2. Rosen DA, Morris JL, Rosen KR, et al. "Nalmefene to prevent epidural narcotic side effects in pediatric patients: a pharmacokinetic and safety study." Pharmacotherapy 20 (2000): 745-9
3. Barsan WG, Seger D, Danzl DF, Ling LJ, Bartlett R, Buncher R, Bryan C "Duration of antagonistic effects of nalmefene and naloxone in opiate- induced sedation for emergency department procedures." Am J Emerg Med 7 (1989): 155-61
4. Kaplan JL, Marx JA, Calabro JJ, GinShaw SL, Spiller JD, Spivey WL, Gaddis GM, Zhao N, Harchelroad FP "Double-blind, randomized study of nalmefene and naloxone in emergency department patients with suspected narcotic overdose." Ann Emerg Med 34 (1999): 42-50
5. Henderson CA, Reynolds JE "Acute pulmonary edema in a young male after intravenous nalmefene." Anesth Analg 84 (1997): 218-9
It is possible that some side effects of nalmefene may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.
More about nalmefene
- Other brands: Revex
Related treatment guides
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.